CCG-1423
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-13991-200 mg |
| CAS # | 285986-88-1 |
| Pricing | 200 mg, USD $540.0 |
| Biological Activity | CCG-1423 is a novel inhibitor of RhoA/C-mediated gene transcription that is capable of inhibiting invasion of PC-3 prostate cancer cells in a Matrigel model of metastasis. |
| Purity | 99.94% |
| MWt | 454.75 |
| Formula | C₁₈H₁₃ClF₆N₂O₃ |